Evonik Industries (ETR:EVK) target price increased to 28.00EUR, reported today by BNP PARIBAS
- Updated: September 18, 2016
Only yesterday Evonik Industries (ETR:EVK) traded 4.60% lower at 29.09EUR. Evonik Industries’s 50-day moving average is 2.57EUR and its two hundred day moving average is 2.03EUR. The last close is up 12.34% from the two hundred day average, compared to the S&P 500 Index which has decreased -0.01% over the same time. Trade volume was was up over the average, with 12,913 shares of EVK changing hands over the typical 6,409 shares..
In a report announced on Monday September 19 2016 BNP PARIBAS upped the target price of Evonik Industries (ETR:EVK) from 0EUR to 28EUR reporting a possible downsideof -0.04%.
On 9/18/2016, Citigroup Corp. reported on Evonik Industries(ETR:EVK) bumped the target price from 0.00EUR to 38.00EUR. At the time, this suggested an upside of 0.31%.
Recent Performance Graphic:
Evonik Industries has a 52 week low of 1.35EUR and a 52 week high of 3.67EUR with a PE ratio of 3. The company’s market cap is presently 0.0 EUR.
More About Evonik Industries (ETR:EVK)
Evonik Industries AG (Evonik) is a Germany-based company engaged in the specialty chemicals sector. The Company’s activities are divided in four segments: Nutrition & Care, produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as in animal nutrition and healthcare products; Resource Efficiency, offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; Performance Materials, produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and Services, includes site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at Company’s sites, and among others. It is a subsidiary of RAG Stiftung.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.